We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$124B
AUM Growth
-$818M
Cap. Flow
-$3.27B
Cap. Flow %
-2.65%
Top 10 Hldgs %
32.71%
Holding
4,253
New
85
Increased
832
Reduced
2,978
Closed
67

Top Buys

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$588M
2
CRH icon
CRH
CRH
+$47.1M
3
CVNA icon
Carvana
CVNA
+$34.4M
4
Q
Qnity Electronics Inc
Q
+$33.9M
5
PINS icon
Pinterest
PINS
+$27.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$326M
2
AAPL icon
Apple
AAPL
+$286M
3
MSFT icon
Microsoft
MSFT
+$251M
4
MRSH
Marsh
MRSH
+$174M
5
AMZN icon
Amazon
AMZN
+$94.5M

Sector Composition

Rank Sector Weight
1 Technology 32.19%
2 Financials 13.22%
3 Consumer Discretionary 10.75%
4 Healthcare 9.82%
5 Communication Services 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FONR
3451
DELISTED
Fonar
FONR
$5.53K ﹤0.01%
298
– –
CCCC icon
3452
C4 Therapeutics
CCCC
$480M
$5.19K ﹤0.01%
2,716
– –
TRIB
3453
Trinity Biotech
TRIB
$7.86M
$5.04K ﹤0.01%
212
+206
+3,433% +$6.07K
DAC icon
3454
Danaos Corp
DAC
$2.55B
$4.99K ﹤0.01%
53
– –
ZLAB icon
3455
Zai Lab
ZLAB
$2.86B
$4.96K ﹤0.01%
281
-10
-3% -$234
RILY icon
3456
BRC Group Holdings
RILY
$304M
$4.88K ﹤0.01%
1,045
+206
+25% +$1.02K
PPBT
3457
Purple Biotech
PPBT
$2.41M
$4.86K ﹤0.01%
739
+631
+584% +$4.58K
KEQU icon
3458
Kewaunee Scientific
KEQU
$104M
$4.68K ﹤0.01%
125
– –
NMRA icon
3459
Neumora Therapeutics
NMRA
$317M
$4.62K ﹤0.01%
2,581
– –
ZSPC
3460
DELISTED
ZSPACE INC NEW
ZSPC
$4.5K ﹤0.01%
383
+154
+67% +$2.93K
HURC icon
3461
Hurco Companies Inc
HURC
$144M
$4.48K ﹤0.01%
290
– –
CANG
3462
Cango Inc
CANG
$89.8M
$4.41K ﹤0.01%
294
+123
+72% +$3.37K
NKTR icon
3463
Nektar Therapeutics
NKTR
$2.57B
$4.23K ﹤0.01%
100
– –
NIU
3464
Niu Technologies
NIU
$162M
$4.14K ﹤0.01%
1,367
-415
-23% -$1.61K
TUR icon
3465
iShares MSCI Turkey ETF
TUR
$221M
$4.13K ﹤0.01%
120
– –
LX
3466
LexinFintech Holdings
LX
$237M
$4.03K ﹤0.01%
1,234
-196
-14% -$805
UTG icon
3467
Reaves Utility Income Fund
UTG
$3.68B
$3.96K ﹤0.01%
+108
New +$4.11K
CRBP icon
3468
Corbus Pharmaceuticals
CRBP
$189M
$3.92K ﹤0.01%
482
– –
METCB icon
3469
Ramaco Resources Class B
METCB
$416M
$3.75K ﹤0.01%
327
-5
-2% -$68
ELUX
3470
DELISTED
AKTIEB. ELECTROLUX B ADR SPNSD
ELUX
$3.54K ﹤0.01%
258
– –
ULBI icon
3471
Ultralife
ULBI
$120M
$3.45K ﹤0.01%
604
– –
FLNA
3472
Filana Therapeutics
FLNA
$45.1M
$3.43K ﹤0.01%
1,734
– –
IMRN
3473
Immuron
IMRN
$8.88M
$3.42K ﹤0.01%
4,496
-1,443
-24% -$2.38K
PLCE icon
3474
Children's Place
PLCE
$55.1M
$3.35K ﹤0.01%
842
– –
ILLR
3475
Triller Group Inc
ILLR
$21.1M
$3.28K ﹤0.01%
10,278
-4,402
-30% -$27.1K
137 138
139
140 141

Similar funds

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
National Pension Service
National Pension Service Jeonju-Si, Jeollabuk-Do, South Korea $132B AUM 28.96% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RhumbLine Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, RhumbLine Advisers held 4,253 positions worth $124B, down 0.66% from $125B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 3.6%. RhumbLine Advisers opened 85 new positions and exited 67, leaving the 4,253-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q4 2025 buy was Qnity Electronics Inc: 399,119 shares worth $32.6M.
  • RhumbLine Advisers added most to iShares Russell 3000 ETF in Q4 2025, an estimated $588M increase.
  • RhumbLine Advisers's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $326M.
  • RhumbLine Advisers fully exited Kellanova in Q4 2025, selling an estimated $52.6M.
  • RhumbLine Advisers's ten largest holdings make up 33% of its $124B portfolio in Q4 2025.
  • RhumbLine Advisers opened 85 new positions and closed 67 in Q4 2025.
  • RhumbLine Advisers's portfolio value fell 0.66% quarter-over-quarter to $124B.

Based on RhumbLine Advisers's 13F filing for Q4 2025, filed 13 Feb 2026.